Delivery Order SPE2DB24D2205-SPE2DB25FEFQR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL Vial 10mL insulin with a ceiling value of $8,157.52 under a firm fixed-price contract. This non-competitive delivery order was executed on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,397.84 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 unit/mL vials (10 mL) under a firm fixed-price contract. This non-set-aside competitive award was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting the federal...
- The Defense Logistics Agency awarded a $9,313.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on July 28, 2025, with completion targeted for July 29, 2025. The order will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This contract was awarded on a competitive basis with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,248.90 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL). This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for completion by July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. NovoLog is a rapid-acting insulin product...
- The Defense Logistics Agency awarded a $6,546.06 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL units), a rapid-acting insulin medication commonly used in military and federal healthcare settings. This non-set-aside, competitively awarded delivery order carries a firm fixed price structure and is scheduled for completion by July 22, 2025, with performance taking place at the contractor's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $3,648.07. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,592.90 for NovoLog 100 Unit/mL vials (10 mL) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $6,072.14. This is a firm fixed-price delivery order issued without set-aside provisions, indicating competitive award to a qualified vendor. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery...
- The Defense Logistics Agency awarded a $6,102.42 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on July 30, 2025, with a completion date of July 31, 2025. This is a firm fixed price, non-set-aside contract to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which...
- The Defense Logistics Agency awarded a $2,045.20 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL) to be delivered by July 29, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating open competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFQRDelivery Order
The Defense Logistics Agency awarded a $2,058.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) with an ultimate completion date of August 1, 2025. This contract was competitively awarded with no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply chain requirements. This award is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The underlying contract supports customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a critical vendor within the federal medical procurement ecosystem.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/31/25 |